Researchers are exploring treatments that will keep people with cystic fibrosis as healthy as possible until a cure is found. In the first plenary at the NACFC, two CF scientists explain the progress of current research.
Site Search
Showing 1 - 10 of 87 results
News
|
|
1 min read
Press Release
|
|
2 min read
News
|
|
2 min read
News
|
|
2 min read
News
|
|
2 min read
Katherine Tuggle, Ph.D.
For those of us without a medication that targets our cystic fibrosis mutation, it's important to remember that our life with CF is a marathon.
Jerry Cahill
New data show positive results in individuals with a single F508del mutation as well as people with two copies of F508del and support continued development of triple combination therapies.
News
|
|
6 min read
The New England Journal of Medicine, the world's most influential and widely read medical periodical, features a study this week about a Phase 2 clinical trial of VX-770, an oral drug in development that targets the root cause of cystic fibrosis.
News
|
|
3 min read
News
|
|
1 min read